Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S45-S52, March 2004

Two-year double-masked comparison of bimatoprost with timolol in patients with glaucoma or ocular hypertension☆

1Cincinnati Eye Institute and University of Cincinnati, Cincinnati, Ohio; 2Baylor College of Medicine, Houston, Texas; and 3Allergan Inc., Irvine, California, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was sponsored by Allergan Inc. Dr. Cohen is a consultant for Allergan Inc, and he has received clinical research support from Allergan Inc. Dr. Gross is a consultant to Alcon, Allergan, and Pfizer; he has received research funding and honoraria for speaking engagements from Alcon, Allergan, and Pfizer. Dr. Cheetham is an employee and share-holder of Allergan Inc. Dr. VanDenburgh is an employee of Allergan Inc. Paula Bernstein is an employee of Allergan Inc. Dr. Whitcup is an employee of Allergan Inc.

PII: S0039-6257(03)00194-2

doi:10.1016/j.survophthal.2003.12.019

Survey of Ophthalmology
Volume 49, Issue 2, Supplement 1 , Pages S45-S52, March 2004

Article Tools

* Image Usage & Resolution